Phase i trial of first-in-class ATR inhibitor M6620 (VX-970) as monotherapy or in combination with carboplatin in patients with advanced solid tumors

Timothy A. Yap, Brent O'Carrigan, Marina S. Penney, Joline S. Lim, Jessica S. Brown, Maria J. De Miguel Luken, Nina Tunariu, Raquel Perez-Lopez, Daniel Nava Rodrigues, Ruth Riisnaes, Ines Figueiredo, Suzanne Carreira, Brian Hare, Katherine McDermott, Saira Khalique, Chris T. Williamson, Rachael Natrajan, Stephen J. Pettitt, Christopher J. Lord, Udai BanerjiJohn Pollard, Juanita Lopez, Johann S. De Bono

Research output: Contribution to journal › Article › peer-review

142 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i trial of first-in-class ATR inhibitor M6620 (VX-970) as monotherapy or in combination with carboplatin in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences